Pre-analytical Sample Handling Conditions and Their Effects on the Human Serum Metabolome
1 other identifier
observational
13
1 country
1
Brief Summary
This study evaluates how blood serum handling conditions can affect the concentrations of \~1,000 serum metabolites and attempts to quantify the degree of attenuation and/or potential bias in epidemiologic associations that may result from less than optimal sample handling conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 12, 2016
CompletedStudy Start
First participant enrolled
March 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedFirst Posted
Study publicly available on registry
March 3, 2016
CompletedMarch 4, 2016
March 1, 2016
Same day
February 12, 2016
March 2, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Selected intensity of biochemicals identified from liquid and gas chromatography with mass ranging from 50 to 800 molecular weight.
Serum metabolomics profiling will be conducted at Metabolon, Inc. after the serum has been handled in a number of different ways (refrigerated for different lengths of time and frozen and thawed various numbers of times)
on day one
Eligibility Criteria
Men and women will be recruited from the area surrounding the BHNRC. There are several thousand government and privately employed workers located within a 10-mile radius of the BHNRC and several residential communities from which a cohort of volunteers will be recruited. The population includes an ethnically diverse group of subjects.
You may qualify if:
- Age 20 to 65 years at beginning of study.
- BMI between 18.5 and 35.0 kg/m2.
You may not qualify if:
- Presence of cardiovascular disease, kidney disease, liver disease, gout, hyperthyroidism, untreated or unstable hypothyroidism, certain cancers, gastrointestinal disease, pancreatic disease, other metabolic diseases, or malabsorption syndromes.
- Unable or unwilling to give informed consent or communicate with study staff.
- Other medical, psychiatric, or behavioral factors that in the judgment of the Principal Investigator may interfere with study participation or the ability to follow the intervention protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
USDA-ARS, Beltsville Human Nutrition Research Center
Beltsville, Maryland, 20705, United States
Biospecimen
serum and urine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Supervisory Research Physiologist
Study Record Dates
First Submitted
February 12, 2016
First Posted
March 3, 2016
Study Start
March 1, 2016
Primary Completion
March 1, 2016
Study Completion
March 1, 2016
Last Updated
March 4, 2016
Record last verified: 2016-03